, ʻO China Chondroitin Sulfate no ka mālamaʻana i ka maʻi maʻi coronary, Arthritis a me ka ho'ōlaʻana i nāʻeha Corneal Purity 98% hale hana a me nā mea hana |Gentolex
English
  • head_banner_01
ʻO Chondroitin Sulfate no ka mālama ʻana i ka maʻi maʻi coronary, ka ʻāʻī a me ka ho'ōla ʻana i nā ʻeha ʻo Corneal maʻemaʻe 98% kiʻi i hōʻike ʻia.
  • ʻO Chondroitin Sulfate no ka mālama ʻana i ka maʻi maʻi coronary, ka ʻāʻī a me ka ho'ōla ʻana i nā ʻeha ʻo Corneal maʻemaʻe 98%
  • ʻO Chondroitin Sulfate no ka mālama ʻana i ka maʻi maʻi coronary, ka ʻāʻī a me ka ho'ōla ʻana i nā ʻeha ʻo Corneal maʻemaʻe 98%

ʻO Chondroitin Sulfate no ka mālama ʻana i ka maʻi maʻi coronary, ka ʻāʻī a me ka ho'ōla ʻana i nā ʻeha ʻo Corneal maʻemaʻe 98%

ʻO ka wehewehe pōkole:

Ka helu CAS: 9007-28-7

Huina mole: C13H21NO15S

Kaumaha molekula: 463.36854

EINECS No.: 232-696-9

ʻAno: pauka

Waihoʻoluʻu: Keʻokeʻo i ke keʻokeʻo

Hiki i ka wai: Soluble i ka wai

Maʻemaʻe: 98%


Huahana Huahana

Huahana Huahana

Huahana Huahana

Inoa Chondroitin sulfate
Helu CAS 9007-28-7
ʻAno molekala C13H21NO15S
Kaumaha molekula 463.36854
Helu EINECS 232-696-9
Ka hoʻoheheʻe wai Hiki i ka wai
Maemae 98%
Waihona E mālama i ka mahana maʻamau
Puka Pauda
kalakala Keʻokeʻo a keʻokeʻo
Hoʻopili ʻeke PE + ʻeke Aluminum

Nā huaʻōlelo like

poly-1(2/3)-n-acetyl-2-amino-2-deoxy-3-o-beta-d-glucopyranurosyl-4-(6)sulfonyl-d-galactose;chondroitinpoly sulfate;chondroitin sulfates;chondroiti nsulfuricacid;chondroitin sulfuric acids;chonsurid;CSO;(5ξ)-2-(Carboxyamino)-2-deoxy-3-O-β-D-glucopyranuronosyl-4-O-sulfo-α-L-arabino-hexopyranose

Ka hopena lāʻau lapaʻau

wehewehe

ʻO Chondroitinsulfate (CS) kahi mucopolysaccharide acidic i unuhi ʻia a hoʻomaʻemaʻe ʻia mai ka ʻiʻo cartilage holoholona.ʻO ka Chondroitin sulfate he mau hale like ʻole e like me A, C, D, E, H a me K. ʻO Chondroitin sulfate ma ke ʻano he nui loa i loaʻa i ka cartilage holoholona, ​​iwi puʻu, iwi ihu (41% i nā puaʻa), bovine, septum lio a me ka trachea (loaʻa i loko. 36% a hiki i 39%), ʻo nā ʻiʻo ʻē aʻe e like me nā iwi wāwae, ligaments, ʻili, cornea, etc.He waiwai loa ka maʻiʻo o ka cartilage iʻa, e like me 50% a 60% i loko o ka iwi mano, a liʻiliʻi loa i loko o ka ʻiʻo pili.

No ka maʻi atherosclerotic coronary, hoʻonui ʻia ka lipids koko a me ka cholesterol, arteriosclerosis, angina pectoris, myocardial ischemia, myocardial infarction, etc.

 

Hana lāʻau lapaʻau

Loaʻa i ka Rapamycin (RAPA) nā hopena ʻaoʻao like me FK506.I loko o ka nui o nā hoʻokolohua lapaʻau, ua ʻike ʻia kona hopena ʻaoʻao e pili ana i ka dosis a hiki ke hoʻohuli ʻia, a ʻaʻole i ʻike ʻia ʻo RAPA ma nā dosis therapeutic he nephrotoxicity nui a ʻaʻohe gingival hyperplasia.ʻO nā mea ʻawaʻawa nui a me nā hopena ʻaoʻao, ʻo ia ka: poʻo, nausea, dizziness, nosebleeds, a me ka ʻeha hui.ʻO nā mea ʻino o ka Laboratory: thrombocytopenia, leukopenia, hemoglobin haʻahaʻa, hypertriglyceridemia, hypercholesterolemia, hyperglycemia, elevated ate enzymes (SGOT, SGPT), elevated lactate dehydrogenase, hypokalemia, Hypomagnesemia, etc. Ua manaʻo ʻia nā pae phosphate plasma he hoʻolōʻihi ʻia ka phosphate excretion mai ke kīpē i hoʻololi ʻia e RAPA-based immunosuppressive therapy.E like me nā immunosuppressants ʻē aʻe, ʻoi aku ka nui o ka loaʻa ʻana o ka maʻi RAPA, me ka manaʻo i hōʻike ʻia e hoʻonui i ka maʻi pneumonia, akā ʻaʻole ʻokoʻa loa ka loaʻa ʻana o nā maʻi kūpono ʻē aʻe me CsA.

 

Nā hopena ʻona

Loaʻa ka Chondroitin sulfate i loko o ke kino cartilage kanaka a me nā holoholona.ʻO ka hoʻomākaukau lāʻau lapaʻau ka nui o ʻelua isomers o chondroitin sulfate A a me chondroitin sulfate C, a ʻokoʻa ka ʻike o ka chondroitin sulfate i loko o ka cartilage o nā holoholona o nā ʻano like ʻole a me nā makahiki.ʻO kāna mau hopena pharmacological penei: hiki i ka chondroitin sulfate ke wehe i nā lipids a me nā lipoproteins i loko o ke koko, e hoʻoneʻe i ka cholesterol mai nā kīʻaha koko a puni ka puʻuwai, e pale a mālama i ka atherosclerosis, a hoʻonui i ka hoʻololi ʻana o nā lipids a me nā momona momona i loko o nā cell.Hiki i ka Chondroitin sulfate ke pale a mālama pono i ka maʻi naʻau coronary.Loaʻa iā ia nā hopena anti-atherosclerosis a me anti-atherogenic plaque hoʻokumu ʻana i nā ʻano hoʻohālike arteriosclerosis hoʻokolohua;hoʻonui i nā lālā coronary a i ʻole ke kahe koko o ka atherosclerosis, a hiki ke hoʻoikaika i ka hoʻokolohua coronary arteriosclerosis a i ʻole embolism.Ho'ōla, hoʻolaʻa hou a hoʻoponopono i ka myocardial necrosis a i ʻole degeneration.Hiki iā ia ke hoʻonui i ka biosynthesis o ka cell messenger ribonucleic acid (mRNA) a me ka deoxyribonucleic acid (DNA) a loaʻa ka hopena o ka hoʻoikaika ʻana i ka metabolism cell.Haʻahaʻa anticoagulant hana.Loaʻa i ka Chondroitin sulfate kahi hopena anticoagulant maʻalahi, a ʻo kēlā me kēia 1 mg o ka chondroitin sulfate A e like me ka hana anticoagulant o 0.45U o heparin.ʻAʻole pili kēia hana anticoagulant i ka antithrombin III e pāʻani i kāna kuleana, hiki iā ia ke hana i ka hana anticoagulant ma o ka ʻōnaehana fibrinogen.Loaʻa i ka Chondroitin sulfate ka anti-inflammatory, ka hoʻōla ʻana i ka ʻeha a me nā hopena anti-tumor.

  • Mua:
  • Aʻe:
    • E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou

    PiliHANA

    E kaomi i ke komo no ka huli ʻana a i ʻole ESC e pani